Cryptococcal Meningitis: Clinical Trials

2 terminated. 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	2	Terminated 2

Follow Cryptococcal Meningitis: new trials by email Literature Review of Cryptococcal Meningitis trials Research Report on Cryptococcal Meningitis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS Mycograb, placebo - Cryptococcal Meningitis	Phase 2	Terminated	Novartis Pharmaceuticals	3	2007-03-01	2008-12-12
Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS Efungumab (Mycograb), placebo, Amphotericin B - Cryptococcal Meningitis	Phase 2	Terminated	Novartis Pharmaceuticals	38	2006-08-01	2009-02-19

Narrower conditions

Meningitis, Cryptococcal (2)

Broader conditions

Bacterial Infections and Mycoses (2)  ·  Central Nervous System Diseases (2)  ·  Central Nervous System Fungal Infections (2)  ·  Central Nervous System Infections (2)  ·  Cryptococcosis (2)  ·  Infections (2)  ·  Meningitis (2)  ·  Meningitis, Fungal (2)  ·  Mycoses (2)  ·  Nervous System Diseases (2)  ·  Neuroinflammatory Diseases (2)

Interventions

efungumab (2)  ·  Amphotericin B (1)  ·  Flucytosine (1)

Sponsors

Novartis Pharmaceuticals (2)

Countries

South Africa (1)  ·  United States (1)